We are live on ! Find out more
HIM

Hillhouse Investment Management Portfolio holdings

AUM $3.13B
1-Year Est. Return 7.29%
This Fund
S&P 500
This Quarter Est. Return
-29.33%
1 Year Est. Return
-7.29%
3 Year Est. Return
+122.05%
5 Year Est. Return
+101.44%
10 Year Est. Return
AUM
$1.34B
AUM Growth
-$2.41B
Cap. Flow
-$1.74B
Cap. Flow %
-130.67%
Top 10 Hldgs %
92.55%
Holding
52
New
2
Increased
8
Reduced
10
Closed
28

Top Buys

Rank Stock Value
1
IQ icon
iQIYI
IQ
+$675M
2
UXIN
Uxin Ltd
UXIN
+$117M
3
META icon
Meta Platforms (Facebook)
META
+$25.2M
4
MRNA icon
Moderna
MRNA
+$16.1M
5
AAPL icon
Apple
AAPL
+$8.66M

Sector Composition

Rank Sector Weight
1 Communication Services 42.21%
2 Financials 23.87%
3 Consumer Discretionary 16.35%
4 Healthcare 15.52%
5 Technology 1.29%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
KANG
51
DELISTED
iKang Healthcare Group, Inc.
KANG
-2,922,834
Closed -$52.9M
CBPO
52
DELISTED
China Biologic Products Holdings, Inc.
CBPO
-2,751,200
Closed -$220M

Similar funds

Hillhouse Investment Management's Q4 2018 Portfolio in Review

As of Q4 2018, Hillhouse Investment Management held 52 positions worth $1.34B, down 64% from $3.74B the previous quarter. Its ten largest holdings account for 93% of the portfolio.

Hillhouse Investment Management withdrew a net $1.74B in Q4 2018, closing 28 positions and reducing 10 holdings. Its most notable exit was China Biologic Products Holdings, Inc., an estimated $220M position sold in full.

By sector, the portfolio is most concentrated in Communication Services at 42% of assets, up from 6.9% a quarter earlier, followed by Financials and Consumer Discretionary.

Against the trend, Hillhouse Investment Management opened a new position in Moderna worth $14.9M.

  • Hillhouse Investment Management's largest Q4 2018 buy was Moderna: 978,434 shares worth $14.9M.
  • Hillhouse Investment Management added most to iQIYI in Q4 2018, an estimated $675M increase.
  • Hillhouse Investment Management's biggest Q4 2018 reduction was BeOne Medicines Ltd, cutting an estimated $589M.
  • Hillhouse Investment Management fully exited China Biologic Products Holdings, Inc. in Q4 2018, selling an estimated $220M.
  • Hillhouse Investment Management's ten largest holdings make up 93% of its $1.34B portfolio in Q4 2018.
  • Hillhouse Investment Management opened 2 new positions and closed 28 in Q4 2018.
  • Hillhouse Investment Management's portfolio value fell 64% quarter-over-quarter to $1.34B.

Based on Hillhouse Investment Management's 13F filing for Q4 2018, filed 14 Feb 2019.